Blood Cancer UK PhD Studentships — 2026–2027

Supervisor-led awards support novel doctoral blood-cancer projects in prevention, early detection/outcome prediction or treatment. Each studentship has a fixed GBP 150,000 value for up to 36 months full-time or 72 months part-time, covering stipend, home-rate fees, research costs and conference dissemination. A student can be named at application or recruited after an award. Research associated with existing trials may qualify; designing or delivering a clinical trial is outside this scheme.

The lead supervisor applies from an eligible UK university, hospital or research institution, with salary secured for the studentship. Early-career supervisors may lead with a tenured co-supervisor at the host. At least one co-supervisor is required; commercial employees are excluded. One application per lead and two per overall host institution. Students need a relevant first/upper-second degree or research track record. Overseas students can be appointed, but international-fee differences need other support. Both institutional signatories must approve by 3 December 2026, 3 pm UK time.